Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Qingwei Cong"'
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Background The co-occurrence of chronic hepatitis B (CHB) and metabolic dysfunction-associated fatty liver disease (MAFLD) has drawn considerable attention due to its impact on disease outcomes. This study aimed to investigate the associatio
Externí odkaz:
https://doaj.org/article/4339413b5a1c43349b527f19ceb3451c
Publikováno v:
Journal of Innate Immunity, Vol 16, Iss 1, Pp 45-55 (2023)
Background: Metabolic-associated fatty liver disease (MAFLD) is one of the most common chronic liver diseases. The underlying pathophysiological mechanisms are intricate and involve various factors. Unfortunately, there is currently a lack of availab
Externí odkaz:
https://doaj.org/article/98fbb59a75894336a661f17079d42b3d
Publikováno v:
Stem Cells International, Vol 2023 (2023)
Metabolic-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease worldwide. However, its pathophysiological mechanism is complicated, and currently, it has no FDA-approved pharmacological therapies. In recent years,
Externí odkaz:
https://doaj.org/article/0ab4b414d4ed489ab5ed254c4a401bd9
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2017 (2017)
Metabolomics as the new omics technique develops after genomics, transcriptomics, and proteomics and has rapid development at present. Liver diseases are worldwide public health problems. In China, chronic hepatitis B and its secondary diseases are t
Externí odkaz:
https://doaj.org/article/d81e1535a2224e61bcd18aabfa272987
Publikováno v:
Oncology Reports. 49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e3e2ec661745d0e287443691778cc6c
https://doi.org/10.3892/or.2023.8550
https://doi.org/10.3892/or.2023.8550
Autor:
Jitao Wang, Qiran Zhang, Jingwen Ai, Dengxiang Liu, Chuan Liu, Huiling Xiang, Ye Gu, Ying Guo, Jiaojian Lv, Yifei Huang, Yanna Liu, Dan Xu, Shubo Chen, Jinlong Li, Qianqian Li, Jing Liang, Li Bian, Zhen Zhang, Xiaoqing Guo, Yinong Feng, Luxiang Liu, Xuying Zhang, Yanliang Zhang, Faren Xie, Shujun Jiang, Wei Qin, Xiaodong Wang, Wei Rao, Qun Zhang, Qiuju Tian, Ying Zhu, Qingwei Cong, Juan Xu, Zhiyun Hou, Nina Zhang, Aiguo Zhang, Hongmei Zu, Yun Wang, Zhaolan Yan, Xiufang Du, Aifang Hou, Yan Yan, Yuanwang Qiu, Hangyuan Wu, Shengjuan Hu, Yanhong Deng, Jiansong Ji, Jie Yang, Jiansheng Huang, Zhongwei Zhao, Shengqiang Zou, Hailei Ji, Guohong Ge, Li Zhong, Song He, Xiaosong Yan, Bian Ba Yangzhen, Ci Qu, Liting Zhang, Shiying Yang, Xiaoqin Gao, Muhan Lv, Qingliang Zhu, Xinxin Xu, Qing-Lei Zeng, Xiaolong Qi, Wenhong Zhang
Publikováno v:
Hepatology international. 16(3)
Data on safety and immunogenicity of coronavirus disease 2019 (COVID-19) vaccination in patients with compensated (C-cirrhosis) and decompensated cirrhosis (D-cirrhosis) are limited.In this prospective multicenter study, adult participants with C-cir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546e401ba711a7b289a029c347a0b5b9
https://pubmed.ncbi.nlm.nih.gov/35403977
https://pubmed.ncbi.nlm.nih.gov/35403977
Publikováno v:
Molecular Medicine Reports; 2016, Vol. 14 Issue 3, p1923-1932, 10p